Singapore, Singapore

Lionel Jianrong Low

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Agency for Science, Technology and Research. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lionel Jianrong Low. Retrieved from https://idiyas.com/inventor/lionel-jianrong-low

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Lionel Jianrong Low

Introduction

Lionel Jianrong Low is a notable inventor based in Singapore, recognized for his contributions to the field of biotechnology. He has made significant strides in the development of therapeutic applications through his innovative research.

Latest Patents

Lionel Jianrong Low holds a patent for Anti-HER2 antibodies. This patent includes antibodies, antigen-binding fragments, and polypeptides that specifically bind to HER2. Additionally, it encompasses nucleic acids and vectors encoding these molecules. The patent also details methods for producing these molecules and their potential therapeutic applications.

Career Highlights

Lionel is affiliated with the Agency for Science, Technology and Research, where he continues to advance his research in biotechnology. His work has been instrumental in the development of new therapeutic strategies.

Collaborations

He has collaborated with esteemed colleagues, including Cheng-I Wang and Angeline Goh, to further enhance the impact of his research.

Conclusion

Lionel Jianrong Low's innovative work in the field of biotechnology, particularly with Anti-HER2 antibodies, showcases his commitment to advancing therapeutic applications. His contributions are significant in the ongoing quest for effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…